No abstract available
Keywords:
Lantus; Mounjaro; Ozempic; Saxenda; Tresiba; Trulicity; Victoza; Wegovy; adverse effects; degludec; dosage; drug interactions; dulaglutide; efficacy; glargine; insulin; lactation; liraglutide; pregnancy; safety; semaglutide; tirzepatide; type 2 diabetes.
MeSH terms
-
Blood Glucose
-
Diabetes Mellitus, Type 2* / diagnosis
-
Diabetes Mellitus, Type 2* / drug therapy
-
Gastric Inhibitory Polypeptide
-
Glucagon-Like Peptides
-
Glycated Hemoglobin
-
Humans
-
Hypoglycemic Agents / adverse effects
-
Insulin Glargine
Substances
-
Blood Glucose
-
Glycated Hemoglobin A
-
Hypoglycemic Agents
-
Insulin Glargine
-
Gastric Inhibitory Polypeptide
-
Glucagon-Like Peptides
-
tirzepatide